Feline histoplasmosis: Fluconazole therapy and identification of potential sources of Histoplasma species exposure

Jennifer M. Reinhart, Kate S. KuKanich, Tracey Jackson, Kenneth R. Harkin

Research output: Contribution to journalReview articlepeer-review

Abstract

Feline histoplasmosis is a systemic fungal infection often treated with itraconazole, which can be cost-prohibitive for some clients. Additionally, although the clinical disease in cats has been documented, sources of Histoplasma species spore exposure in cats have yet to be thoroughly investigated. The objectives of this study were to compare the outcomes of cats with histoplasmosis treated with fluconazole to those treated with itraconazole, and to evaluate possible sources of exposure for affected cats. Medical records from feline patients with confirmed histoplasmosis (n = 32) at Kansas State University were systematically reviewed and follow-up was performed by owner telephone interview. Cats treated with fluconazole (n = 17) had similar mortality and recrudescence rates when compared with cats treated with itraconazole (n = 13). Thus, fluconazole may be a viable alternative therapy for the treatment of feline histoplasmosis. Eleven cats were housed strictly indoors and possible sources of exposure reported for these cats included potted plants (5/11) and unfinished basements (6/11).

Original languageEnglish (US)
Pages (from-to)841-848
Number of pages8
JournalJournal of Feline Medicine and Surgery
Volume14
Issue number12
DOIs
StatePublished - Dec 2012
Externally publishedYes

ASJC Scopus subject areas

  • Small Animals

Fingerprint Dive into the research topics of 'Feline histoplasmosis: Fluconazole therapy and identification of potential sources of Histoplasma species exposure'. Together they form a unique fingerprint.

Cite this